AAS
FLGT icon

Ameritas Advisory Services’s Fulgent Genetics FLGT Stock Holding History

Ameritas Advisory Services’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-82
Closed -$1.63K – 2400
2025
Q2 		$1.63K Buy
+82
New +$1.6K ﹤0.01% 2535
2023
Q2 		– Sell
-89
Closed -$2.67K – 1236
2023
Q1 		$2.67K Buy
+89
New +$2.86K ﹤0.01% 2324

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ameritas Advisory Services's FLGT Position: Q3 2025 in Review

Ameritas Advisory Services sold out of Fulgent Genetics (FLGT) in Q3 2025, closing a stake of 82 shares — an estimated $1.63K sold.

Ameritas Advisory Services first reported a position in FLGT in Q1 2023 and held it in 2 quarters. The position peaked at $2.67K in Q1 2023. 163 funds tracked by Wall St. Rank hold FLGT as of Q3 2025.

  • Ameritas Advisory Services reported no remaining Fulgent Genetics position as of Q3 2025 after selling out during the quarter.
  • Ameritas Advisory Services sold 82 Fulgent Genetics shares in Q3 2025, an estimated $1.63K.
  • Ameritas Advisory Services first reported a position in Fulgent Genetics in Q1 2023 and held it in 2 quarters.
  • Ameritas Advisory Services's Fulgent Genetics position peaked at $2.67K in Q1 2023.
  • 163 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2025.

Based on Ameritas Advisory Services's 13F filing for Q3 2025, filed 6 Nov 2025.